The purpose of this study was to examine whether caffeine (CAF), carnitine (CAR), or CAP+CAR mixture administration affects exercise endurance time via carnitine metabolism. Water (CON), CAF, CAR, or CAF+CAR mixture was administered to five male rugby athletes participating in this study by a randomized double-blind fashion who were made to ride a cycle ergometer for exercise. The CAF effect on exercise endurance time was small, but the CAR trial significantly increased the exercise endurance time compared with CON trial; a further CAP +CAR mixture trial had greater effects on the exercise endurance time than those of a CON, CAF, or CAR trial. A CAR or CAF+CAR mixed trial increased uri nary nonesterified carnitine (NEC) and total carnitine (TCAR), but no changes were ob served in acid-soluble acylcarnitine (ASAC) and acid-insoluble acylcarnitine (AIAC) excre tion. A CAR or CAF+CAR mixed trial resulted in higher levels of plasma NEC, ASAC, and TCAR fractions than the CON and CAF trials did on exhaustion time. Total cholesterol, triglyceride, and free fatty acid in blood were significantly increased at exhaustion time, but they were not affected in the CAF or the CAR trial. These results suggest that carnitine in gestion could promote fat oxidation, resulting in higher endurance performance in athletes, and especially these ergogenic effects of carnitine coingested with caffeine may be greater than those of carnitine alone.
Most human skeletal muscle uses stored glycogen for the production of energy at the first stage of exercise (1) . During prolonged exercise, it is also required that free fatty acid is used to generate energy for working muscular activity. Therefore it has been reported that fat metabolism is stimulated and muscle glycogen is spared during the active exercise periods to prolong ex ercise endurance time and to delay fatigue (2, 3) .
Carnitine (CAR) is an essential factor that plays an important role in the transportation of long-chain fatty acids into the mitochondria matrix during the process of fat oxidation. CAR is synthesized from the essential amino acids, lysine and methionine. Ascorbate, vitamin B6, and iron are also required for the synthesis of CAR. Therefore it is believed that the source of substrates for CAR biosynthesis is mainly by food consumed (4) . Especially, since muscle tissues have no CAR biosynthe sis ability and CAR transported into the muscle is drained during the long-term exercise period, CAR re quired for the supply of fatty acids into muscle mito chondria must be provided mainly by exogeneous in take (5, 6) . It has been reported that endogenous CAR synthesized in the body is insufficient for fat metabolism during active exercise (7) . Therefore many attempts have been made to increase the exercise endurance time and exercise ability by supplementing the needed CAR from exogenous sources (8) (9) (10) (11) (12) (13) (14) .
We have studied lipolytic food component effects on endurance performance in rats and in human athletes. The lipolytic food means that the food stimulates lipoly sis and/or fat oxidation at rest or during exercise in hu mans. We have studied and surveyed the lipolytic foods that are most likely useful for athletes, such as caffeine (15, 16) , capsaicin (17) (18) (19) , (-)-hydroxycitrate (20, 21) , and fructose (22) .
It has been also reported that caffeine (CAF) inhibits phosphodiesterase, an enzyme-degrading cAMP, conse quently increasing CAMP concentration in the adipose tissues and adrenal gland. The increased cAMP concen tration caused the stimulation of catecholamine secre tion from the adrenal medulla and consequently caused the stimulation of stored fat mobilization (14) . There fore it has been suggested that CAP can induce an in crease in free fatty acids in blood and spare glycogen in liver and muscle (23) (24) (25) . However, the effects of CAF Subjects. Five healthy rugby players participated in this experiment. They understood and agreed to the purpose of the study and gave written consent to partic ipate. They had no disease and had not used drugs for at least 1y. Even though they were not habitual caffeine consumers, we educated them to never take drinks con taining caffeine. The subjects were trained for at least 5y and had an average maximal oxygen uptake (VO2max) of 53.2mL/kg/min. VO2max was measured by using an indirect calorimetric technique during an incremental exercise bout, as previously reported (15) . Subject characteristics are shown in Table 1 . The exper iment was approved in accordance with the Helsinki Declaration of 1975.
Subjects arrived at the laboratory 150 min before en durance exercise. They were given 640kcal of formal diet (Table 2 )120 min before exercise. They were then offered experimental drinks including caffeine (CAF; 5mg/kg in 250mL), carnitine (CAR; 15g/250mL), caffeine+carnitine (CAF+CAR; 5mg/kg of caffeine and 15g of carnitine in 250mL), or water (250mL) 1h after the meal. After the diet, rest-expired gas was measured for 5 min. The International Olympic Committee (IOC) agreed that caffeine ingestion is illegal if urinary caffeine is over 12mg/L. Jackman et al. (26) reported that 6 mg/kg of caffeine ingestion before exercise does not ex ceed the IOC's limitation. From this point of view, we hypothesized that 6mg/kg of caffeine ingestion would be the maximum amount in humans. Therefore 5 mg/kg of caffeine were selected in this experiment.
Experimental procedure. A randomized double-blind fashion was used to choose the different administration substances for subjects and examiners. The intervals between each trial were at least 1wk. A bicycle ergome ter (Mornak, Sweden) was used to carry an exercise load of this experiment on 60% and 80% of VO2max. The exhaustion time was determined by deciding the point when the subject cannot continue pedaling at 50rpm. The exercise endurance time was measured by counting the time from starting the experiment to ex haustion time. Blood samples were taken from the sub jects 1h before exercise (just before supplement admin istration), 1 min before exercise (1h postadministra tion), and during exhaustion time shown in Fig. 1 . They did stretching exercises for 2-3 min after 5 min of resting metabolic rate (RMR) measurement at 10 min before exercise. And a 3-way catheter was inserted in the anticubital vein before exercise for blood collection every 10 min of exercise for 40min and at 45 min. They exercised on the cycle ergometer at 60% VO2max for 45min, and exercise intensity was then increased at Table 2 . Composition of diet offered to subjects. 80% VO2max until the subjects were exhausted. Expired gas during exercise was collected in a Douglas bag (Fukuda Sangyo, Tokyo, Japan) every 2 min at the first period of exercise at 60% VO2max and 1 min at 80% of VO2max. The experimental procedures are shown in Fig. 1 . Endurance capacity RESULTS A CAR trial significantly increased endurance exer cise time compared with a CON or CAF trial (Fig. 2) . Furthermore, a CAF+CAR mixture trial had a greater effect on endurance capacity than CAR alone, as shown in Fig. 2 .
Blood carnitine levels
The effects of an administration supplement (CON, CAF, CAR, and CAF+CAR mixture) on plasma CAR lev els are shown in Table 3 . In the rest condition, all CAR levels were the same between the various administra tion groups. Plasma CAR levels at 1h after administra tion in CON and CAF trials did not differ from the before levels. However, the CAF+CAR mixture trial showed higher plasma NEC, ASAC, and TCAR concentrations after administration at 1h. Plasma CAR levels after ex ercise (at exhaustion time) were not different between CON and CAF trials, but CAR and CAF+CAR mixture trials significantly increased blood NEC, ASAC, and TCAR levels. The CAF+CAR mixture trial increased The results of urinary CAR excretion during 24h are presented in Fig. 3 . The variation under rest conditions was small in comparison to the variation among sub jects under exercise conditions. Even though the excre tion of all fractions of CAR was higher in control sub jects under the exercise conditions than under the nonexercise conditions, there was no statistical signifi cance between them. Therefore exercise did not affect CAR excretion. A CAR or CAF+CAR mixture trial has significantly higher NEC and TCAR than among sub jects who were in rest, a CON trial, or a CAF trial. However, urinary excretions of ASAC and AIAC were not statistically different between the groups.
The effects of acute exercise and various trial sub stances on plasma TC, TG, and FFA levels are shown in Table 4 . The TC level at 1h after administration in a CAR trial was lower than in a CAF+CAR trial. The TG level was unchanged in all groups. However, FFA con centrations at 1h after the exercise in CAR and CAF+CAR trials were significantly lower than in the CON and CAF trials.
DISCUSSION
In this study, we asked two meaningful questions. The first, whether a single bout of CAF or CAR and CAR coingested with caffeine (CAF+CAR) trial affect exer cise endurance time. The second, whether CAR metabo lism might be modulated to change time and blood lipid profiles by different trial substances and/or prolonged Most previous studies have been done with human subjects whose diets have had high-fat and high-protein (30) . Korean athletes participating as subjects in this study were good models because the Korean diet has a relatively low CAR content compared with non-Asian diets, and Koreans do not consume many drinks con taining CAF (31) . The effects of CAR ingestion on exer cise-related parameters are controversial, and no clear conclusion has yet been reached. For example, it has been reported that a CAR supplement (2g/d) for 28 d on athletes resulted in enhancing exercise performance by increasing the utilization of fat and glycogen spar ingly on muscle (32) . Three grams of CAR injection be fore a 40 min exercise showed decreasing respiratory quotient (RO) and increasing fat oxidation (33) . How ever, Oyono-Enguelle et al. (34) and Vukovich et al. (35) provided data showing that endogenous CAR is suffi cient for fat metabolism in a normal person, and CAR is not a rate-limiting substance for fat metabolism if CoA is sufficient.
Carlin et al. (36) and Soop et al. (37) insisted that a CAR trial did not affect energy metabolism during exer cise because CAR is released to the blood after being acylated in the liver. CAF administration on fat metabo lism is also controversial (38) (39) (40) (41) (42) . It has been generally accepted that the effects of CAF administration during exercise are different, depending on various factors in cluding exercise intensity, methods of administration, and state of training, and CAF administration had a glycogen-sparing effect by increasing blood FFA in a long exercise (more than 30 min). The physiological availability of CAR orally administrated is generally very low, and it is different for every person. Previous studies have shown that 2g of CAR a day resulted in about 13% physiological availability (43) , and a peak of CAR concentration in blood was shown after 3h postadministration (44, 45) . However, 15g of CAR showed that high blood CAR levels were reached within 30 min, remaining at that level for 3h (46) .
In the present study, a CAR trial (15g/d) resulted in increasing exercise endurance time. A CAF+CAR mix ture trial showed much longer exercise endurance time compared with a CON trial. However, a CAF trial alone did not affect exercise endurance time. Vecchiet et al. (47) have reported that pretreatment L-CAR (2g) in creased work capacity with increasing VO2max, but without affecting RQ. They discussed two possible mechanisms for their results: 1) The administration of CAR during exercise might reduce acyl-CoA accumula tion, which has adverse effects on energy production;
2) The administration of CAR might promote an in crease of glucose utilization by buffering the intramito chondrial acetyl CoA/CoA ratio. In this study, a CAP+CAR mixture trial showed decreased R0, but no change in VO2max (data not shown). Previous studies have shown that exercise increased plasma acylcarni tine, which is mostly acetylcarnitine (10) . Our results also show that acute exercise is associated with a signif icant increase in plasma ASAC (Table 3) . Plasma CAR levels during exercise might be dependent on exercise intensity and the administration substances. Lennon et al. (48) have shown that plasma NEC levels decreased significantly after exercise. On the other hand, ASAC increased in moderately trained subjects. Our study also showed that NEC levels slightly decreased and that ASAC levels increased with a CON or CAF trial. This alternation of CAR levels was explained by the enhanced oxidation of both pyruvate and fatty acids in muscles during prolonged exercise (49) . Plasma CAR concentrations at exhaustion time were significantly increased in CAR-supplemented groups. Only CAF trial failed to affect plasma CAR lev els, but a CAF+CAR mixture trial 1h postadministra tion showed higher plasma TCAR levels than those of the other conditions.
Increased urinary CAR excretion has been shown to occur in subjects on exercise days, compared with sub jects on nonexercise control by other investigators (50) . Urinary CAR excretion was not changed by a CAF trial compared with CON. Any fractional CAR excretions were not significantly different between the day of exer cise CON and the nonexercise day in this study ( Fig. 3) . Although a CAR or a CAF+CAR trial increased the uri nary excretion of NEC, the TCAR, ASAC, and AIAC lev els did not change as a result of a CAR trial. The excre tion of urinary CAR was responsible for maintaining blood CAR concentrations. Therefore the urinary excre tion of ASAC and AIAC is one factor to keep high blood ASAC and AIAC levels in our study.
Exercise has been associated with variable effects on blood lipid profile. Therefore we conducted the study to see whether acute exercise and/or a CAF, CAR, or CAF+CAR mixture trial affects blood TC, TG, and FFA levels. Aerobic exercise increases HDL-cholesterol with moderate exercise in obese women (51) and men (52) , but other studies (53, 54) have shown little or no effect on TC, TG, and LDL cholesterol. In our study, acute ex ercise increased TC, TG, and FFA levels, but a CAF and a CAR trial did not affect them (Table 4) . However, a CAF+CAR mixture trial at 1h postadministration showed significantly higher plasma FFA concentration in comparison with the rest condition. And the level of a CAF+CAR trial at 1h after exercise then was signifi cantly lower than that of a CAF trial. We therefore could carefully suggest that a CAF+CAR mixture trial would promote fatty acid oxidation from plasma FFA during exercise. It has been reported that the ability of muscle to oxidize fat has been thought to be limited by CAR palmitoyl transferase activity to transport fatty acid across the mitochondrial membrane during pro longed exercise (55) . Our results showed that FFA levels under all administration conditions were higher during exhaustion time in comparison with a rest situation. Although CAF or CAR alone had no effect on plasma FFA levels, their exhaustion time was longer than in a CON or CAF trial. Another important form of fat for oxi dation by muscle during exercise is intramuscular TG (56 
